Previous Article | Next Article ![]()
Infection and Immunity, September 2001, p. 5385-5394, Vol. 69, No. 9
Department of Microbiology, University of
Colorado Health Sciences Center, Denver, Colorado
80262,1 and Department of
Biochemistry, University of Otago, Dunedin, New
Zealand2
Received 22 February 2001/Returned for modification 7 May
2001/Accepted 15 June 2001
The expression of many virulence factors in Pseudomonas
aeruginosa is dependent upon environmental conditions,
including iron levels, oxygen, temperature, and osmolarity. The
virulence of P. aeruginosa PAO1 is influenced by the
iron- and oxygen-regulated gene encoding the alternative sigma factor
PvdS, which is regulated through the ferric uptake regulator (Fur). We
observed that overexpression of PvdS in strain PAO1 and a
Pseudomonas aeruginosa is
an opportunistic bacterium that can be particularly problematic for
those predisposed to lung infections, such as those with cystic
fibrosis (CF). At least part of the pathogenic potential of this
organism stems from its ability to produce a myriad of extracellular
virulence factors, including toxins, siderophores, and proteases. The
global iron regulator Fur (ferric uptake regulator) contributes to the
expression of many of these virulence factors (34). Fur
orchestrates a cascading effect on regulators causing the expression of
virulence factors through the production of the alternative sigma
factor PvdS. PvdS belongs to the extracytoplasmic factor class of
regulatory proteins (55). PvdS, in turn, regulates
additional virulence genes (e.g., toxA, which encodes
exotoxin A) and other regulatory genes, including regA and
ptxR (54).
P. aeruginosa produces several proteases, including an
elastase (LasB protease), a LasA protease, and an alkaline protease, that have been shown to be important in tissue damage during infection. These proteases are often under complex regulation. For example, expression of lasB depends on an intact lasR gene
(19) and the autoinducer PAI (38). Often, as
in the case of the metalloprotease LasB, efficient production and
processing of certain proteases require zinc and calcium ions
(36). Although protease production by P. aeruginosa has been extensively studied, no iron-regulated protease has been reported in this organism. One of the functions of
proteases is to hydrolyze peptides for nutrient acquisition either by
degrading host enzymes or even by causing tissue damage to further the
survival of the bacterium. The host iron-binding proteins lactoferrin
and transferrin are normal constituents of airway secretions which are
important in host defenses by limiting the availability of iron, an
essential microelement, for use by microbial pathogens
(18). Both Pseudomonas- and neutrophil-derived proteases may contribute to lung injury in CF patients through their
ability to cleave lactoferrin and transferrin (5, 11). Britigan et al. demonstrated that degradation of lactoferrin and transferrin occurs in vivo in the airways of individuals with CF and
other forms of chronic lung disease; however, such degradation products
were not detectable in bronchoalveolar lavage samples from healthy
controls (6). This suggests that the degradation of these
proteins plays a role in the pathogenicity of P. aeruginosa (5). Here, we describe an endoprotease in P. aeruginosa that hydrolyzes casein, lactoferrin, transferrin,
elastin, and decorin and contributes to the ability of this
opportunistic pathogen to persist in a model of chronic pulmonary infection.
Bacterial strains and media.
The strains and plasmids used
in this study are shown in Table 1.
P. aeruginosa PAO1 is the prototypic strain and has been previously described (23). Clinical and environmental
isolates were obtained from a variety of sources. Brain heart infusion (BHI) broth supplemented with the appropriate antibiotic was used for
strain maintenance. P. aeruginosa PAO1-based mutant strain
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5385-5394.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of an Endoprotease (PrpL) Encoded
by a PvdS-Regulated Gene in Pseudomonas
aeruginosa
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
pvdS::Gm mutant resulted in
increased pyoverdine production and proteolytic activity compared to
when PvdS was not overexpressed. To identify additional PvdS-regulated genes, we compared extracellular protein profiles from PAO1 and the
pvdS::Gm mutant grown under
iron-deficient conditions. A protein present in culture supernatants
from PAO1 but not in supernatants from
pvdS::Gm was investigated.
Amino acid sequence analysis and examination of the genomic database of
PAO1 revealed that the N terminus of this 27-kDa protein is identical
to that of protease IV of P. aeruginosa strain PA103-29
and is homologous to an endoprotease produced by Lysobacter
enzymogenes. In this study, the gene encoding an endoprotease
was cloned from PAO1 and designated prpL (PvdS-regulated
endoprotease, lysyl class). All (n = 41) but one of
the strains of P. aeruginosa, including clinical and
environmental isolates, examined carry prpL. Moreover, PrpL production among these strains was highly variable. Analysis of
RNase protection assays identified the transcription initiation site of
prpL and confirmed that its transcription is iron
dependent. In the
pvdS::Gm
mutant, the level of prpL transcription was iron independent and decreased relative to the level in PAO1. Furthermore, transcription of prpL was independent of PtxR, a
PvdS-regulated protein. Finally, PrpL cleaves casein, lactoferrin,
transferrin, elastin, and decorin and contributes to PAO1's ability to
persist in a rat chronic pulmonary infection model.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
pvdS::Gm was generated by replacing
a 460-bp AccI-HincII fragment from the
pvdS coding sequence with a gentamicin resistance
(Gmr) cassette (33). P. aeruginosa PAO1-based mutant strain
prpL::Gm was generated by replacing
a 1,343-bp BglII-SphI fragment from the
prpL coding sequence with a Gmr
cassette. P. aeruginosa PAO1-based mutant strain
ptxR::Gm has been described
previously (50). Chelexed and dialyzed tryptic soy broth
(D-TSB) containing 1% glycerol and 50 mM glutamate was used as a
low-iron medium and was supplemented with FeCl3
at 50 µg/ml for use as a high-iron medium. Antibiotics were used at the following concentrations: for Escherichia coli,
ampicillin at 100 µg/ml, gentamicin at 15 µg/ml, kanamycin at 100 µg/ml, and tetracycline at 15 µg/ml; for P. aeruginosa,
carbenicillin at 500 µg/ml, gentamicin at 75 µg/ml, and
tetracycline at 150 µg/ml.
TABLE 1.
Strains, plasmids, and primers used in this study
Measurement of pyoverdine production.
The production of
pyoverdine by P. aeruginosa was measured
spectrophotometrically by a modification of the method described by
Meyer and Abdallah (30). Bacteria were cultured in King's B medium (27) to late stationary phase (optical density at
600 nm of
3). Supernatants were normalized for differences in cell density, and the absorbances were measured at 405 nm for low-iron cultures or 380 nm for high-iron cultures. The concentration of pyoverdine was calculated by using the extinction coefficient for
either pyoverdine (1.9 × 10
4
M
1cm
1) or for
ferripyoverdine (1.4 × 104
M
1 cm
1) as follows:
molar concentration = absorbance at 405 or 380 nm/extinction coefficient.
Total proteinase assay. Total extracellular proteinase activity in culture supernatants was measured by using a modification of the method described by Farley (15). P. aeruginosa PAO1 was grown in King's B medium. One milliliter of cell-free supernatant was added to 15 ml of sodium phosphate buffer (pH 8) containing 50 mg of Azocoll protease substrate and incubated with shaking at 37°C. The absorbance was measured at 520 nm at various times. The rate of proteolysis was expressed as the change in absorbance at 520 nm per milliliter per hour.
Identification of PvdS-regulated proteins.
P.
aeruginosa PAO1 and
pvdS::Gm
were grown in D-TSB supplemented with glycerol and glutamate without
the iron supplement at 32°C for 15 h. Proteins from culture
supernatants were precipitated with ammonium sulfate (0.47 g/ml) and
dialyzed overnight against Tris-buffered saline. The proteins were
subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) and stained with Coomassie brilliant blue. A
27-kDa protein detected in supernatants from PAO1 but not in
supernatants from
pvdS::Gm was N
terminally sequenced by Macromolecular Resources (Colorado State
University, Fort Collins, Colo.). The nucleotide sequence of the
resulting amino acid sequence was deduced by using a codon bias for
P. aeruginosa (56), and a blastn search against
the Microbial Genomes Database (www.ncbi.nlm.nih.gov/BLAST/unfinishedgenome.html) was performed.
DNA manipulations and analysis. The prpL gene from P. aeruginosa PAO1 was cloned as a 5,886-bp BclI fragment into pBluescript SK(+) (Stratagene). Plasmid and chromosomal DNAs were isolated by standard procedures (43). Taq polymerase and 18- or 23-mer primers (Gibco BRL) (Table 1) were used for PCR with a GeneMate thermal cycler. DNA sequence analysis was performed by the dideoxy-chain termination method (44) with Sequenase (United States Biochemical).
Demonstration of protease activity using D-BHI skim milk agar. Various strains of P. aeruginosa were grown in D-TSB supplemented with glycerol and glutamate without the iron supplement at 32°C for 15 h. Extracellular proteins were precipitated with ammonium sulfate. Protease activity was determined by spotting the precipitated proteins onto D-BHI skim milk agar plates (48) and measuring the zone of hydrolysis produced after incubation of the plates at 37°C for 24 to 38 h.
Substrate specificity of PrpL.
P. aeruginosa PAO1
and
prpL::Gm were grown in D-TSB
supplemented with glycerol and glutamate without the iron supplement at
32°C for 15 h. Extracellular proteins from each culture were partially purified by removing proteins that bound DEAE-52 (for example, ToxA). Proteins that did not bind DEAE-52 were precipitated with ammonium sulfate and dialyzed against buffer A (50 mM Tris [pH
7.4], 50 mM NaCl). Aliquots were stored at
80°C until used. Approximately 10 µg of lactoferrin, transferrin, or decorin
(Sigma) was incubated at 37°C for 1 h with precipitated proteins
from P. aeruginosa PAO1 and
prpL::Gm in a final concentration of
10 mM Tris (pH 7.5)-2 µM CaCl2-40 µM KCl.
Degradation products were analyzed by SDS-PAGE (10% acrylamide for
lactoferrin and transferrin and 4 to 15% acrylamide for decorin) and
stained with Coomassie brilliant blue.
Immunoblot analysis.
Lactoferrin was incubated with
extracellular proteins from P. aeruginosa PAO1 and
prpL::Gm and subjected to SDS-PAGE.
Proteins were transferred to a nitrocellulose membrane, which was then blocked with phosphate-buffered saline (PBS)-5% nonfat dried
milk-0.1% (vol/vol) Tween 20 at room temperature for 1 h. Rabbit
anti-human lactoferrin antibody (ICN Biomedicals, Inc.) and anti-rabbit
immunoglobulin G were used at dilutions of 1:100,000 and 1:50,000,
respectively. Detection was performed with reagents from an ECL+Plus
kit (Amersham Pharmacia Biotech) and chemiluminescent film.
Elastin-Congo red assay. Elastase activity was determined as previously described (35, 42). Briefly, supernatants were added to an elastin-Congo red substrate (Sigma) and incubated for various times at 37°C. Insoluble elastin-Congo red was pelleted at 1,200 × g for 10 min at room temperature, and the absorbance of the soluble Congo red in the supernatant was measured at 495 nm. Elastase activity was determined by interpolation from a standard curve of known elastase concentrations.
Agarose bead rat lung model.
Beads were prepared at a final
concentration of 107 to 108
each of P. aeruginosa PAO1 and
prpL::Gm bacteria per ml of melted agarose. Heavy mineral oil and 2% agarose in PBS were warmed to 50°C. The bacteria were added to 10 ml of molten agarose and mixed thoroughly. Ten milliliters of warmed mineral oil was added, and the
combination was mixed thoroughly. The agarose bead-oil suspension was
allowed to solidify quickly in an ice bath for 2 min. The beads were
then washed once with 0.5% sodium deoxycholate in PBS, twice with
0.25% sodium deoxycholate in PBS, and thrice with PBS. Young, adult
Sprague-Dawley rats were anesthetized, and a small midline cervical
incision was made to expose the trachea. Approximately 0.1 ml of the
bead suspension was placed in a distal bronchus via a 20-gauge Teflon
catheter over the needle. After the inoculate had been instilled, the
incision was closed with 3-0 silk. Animals were euthanatized with
pentobarbital at 7 days postinfection. The lungs were harvested and
homogenized in PBS with a model 985-370 Tissue-Tearor (Biospec
Products, Inc.). Serial dilutions were plated onto both selective and
nonselective BHI agar. All experiments involving animals were performed
in accordance with the guidelines of the Animal Care and Use Committee
at the University of Colorado Health Sciences Center.
RNase protection assays. RNase protection assays were performed as previously described (3) using the Riboprobe system (Promega). The radiolabeled riboprobes were generated by runoff transcription from the T7 promoter of linearized pCR2.1 (Invitrogen) containing suitable cloned PCR fragments. The expression of the constitutively expressed omlA gene was measured to confirm that the same amount of RNA was used in each reaction. The relative intensity of each transcript was quantified with a Bio-Rad Personal FX PhosphorImager. Image analysis was done with Quantity One software (version 4.0.3) from Bio-Rad.
Southern blot hybridization. Southern blot hybridization was performed by following published procedures (43). DNA probes were prepared by radiolabeling amplified DNA fragments with a rediprime II random prime labeling system (Amersham Pharmacia Biotech). The primers used to generate the 727-bp probe for prpL are shown in Table 1.
| |
RESULTS |
|---|
|
|
|---|
Effects of PvdS on pyoverdine production and proteolytic
activity.
To examine the effects of PvdS on pyoverdine production
and proteolytic activity, P. aeruginosa PAO1 was transformed
with the vector pVLT31 or pPVD31 (pVLT31 containing pvdS
under the control of the tac promoter). As shown in Table
2, when PAO1/pPVD31 was grown in the
presence of isopropyl-
-D-thiogalactopyranoside (IPTG), pyoverdine production was
2.5 times that of uninduced PAO1
containing either pVLT31 or pPVD31. In addition, proteolytic and
elastolytic activities were
3 and
1.5 times, respectively, that
of uninduced PAO1 containing either pVLT31 or pPVD31 (Table 2). When
the
pvdS::Gm mutant was complemented
with pvdS, pyoverdine production was
40 times greater
when PvdS was expressed using IPTG than when it was not. An increase in
proteolytic activity was also observed when PvdS was expressed in the
pvdS::Gm mutant. Finally, when
pvdS::Gm was grown in the presence
of IPTG, its elastolytic activity was restored to the wild-type level
(Table 2). Taken together, these data suggest that PvdS influences some of the proteolytic and elastolytic activities of P. aeruginosa.
|
Identification of a PvdS-regulated gene.
Examination of
protein profiles comparing the proteins expressed by P. aeruginosa PAO1 and the
pvdS::Gm mutant revealed that several proteins are regulated under low-iron conditions by the alternative sigma factor PvdS (Fig. 1).
In this study, we focused on a 27-kDa protein that is present in PAO1
but not in the
pvdS::Gm mutant.
N-terminal sequencing of this protein revealed an N terminus of
AGYRDGFGAS. This sequence is identical to that of protease IV described
in P. aeruginosa strain PA103-29 (12). By using P. aeruginosa codon bias (56), the nucleotide
sequence of the N terminus sequence was determined. This led to the
identification of an open reading frame in the P. aeruginosa
PAO1 genome database corresponding to PA4175 (bp 4671318 to 4672706). A
blastn search against the Microbial Genomes Database
(www.ncbi.nlm.nih.gov/BLAST/unfinishedgenome.html) using PA4175
indicated a significant hit (2
84) with an
endoprotease ArgC precursor from Lysobacter enzymogenes. The
L. enzymogenes endoprotease gene encodes a serine
protease that cleaves substrates C terminal to arginine and, to a
lesser extent, lysine residues (61). Alignment of the
putative unprocessed endoprotease from P. aeruginosa PAO1
and the endoprotease from L. enzymogenes using a blastp
search (www.ncbi.nlm.nih.gov/gorf/bl2.html) indicated that the proteins
are 44% identical (Fig. 2). In addition, the active site (serine, aspartate, and histidine) of the L. enzymogenes endoprotease is conserved in the putative P. aeruginosa endoprotease (Fig. 2). The L. enzymogenes
endoprotease is synthesized as a preproprotein that is subsequently
processed into its mature extracellular form. It has a 24-residue
signal sequence, an
195-residue pro region, and an
244-residue
catalytic domain (61).
|
|
Analysis of protease activity on D-BHI skim milk agar.
The
gene encoding the endoprotease homologue from PAO1 was cloned and
designated prpL. To confirm that the 27-kDa extracellular protein detected in P. aeruginosa PAO1 but not in the
pvdS::Gm mutant had proteolytic
activity, proteins precipitated from supernatants of cells grown in
low- and high-iron media were analyzed for the ability to degrade
casein. PAO1 produces proteases under both low- and high-iron
conditions in cultures as early as 6 h, and protease production is
increased when iron is limiting. As shown in Fig.
3, when PAO1 was grown for 6 h under
low-iron conditions, the zone of hydrolysis which measured protease
activity was 13.1 ± 0.3 mm, compared to 8.8 ± 0.3 mm when
the bacteria were grown under high-iron conditions. Similarly, when
cultures were grown for 12 and 18 h, greater zones of hydrolysis
were observed under low-iron conditions than under high-iron
conditions. Moreover, at least some of the genes encoding such
proteases are regulated by the alternative sigma factor PvdS, as seen
by the smaller zone of hydrolysis produced by
pvdS::Gm compared to the zone
produced by PAO1 (Fig. 3). In addition, when sequences internal to
prpL were replaced with a gentamicin cassette, protease
activity was greatly reduced (Fig. 3). For example, when
prpL::Gm was grown under low- and
high-iron conditions for 6 h, the zone of hydrolysis measured
8.4 ± 0.3 and 6.5 ± 0 mm (the diameter of the disk), respectively (Fig. 3). Even when
prpL::Gm was grown for 18 h under low-iron conditions, protease activity was still less than when
PAO1 was grown for 6 h under low-iron conditions (Fig. 3). Therefore, the protease activity detected in extracellular proteins from
prpL::Gm indicates that PrpL is
a major contributor to this protease activity, as observed at all of
the time points examined.
|
Substrate specificity of PrpL and immunoblot analysis.
Because
PrpL is present under low-iron conditions, it seemed reasonable to
determine if PrpL is involved in iron acquisition when lactoferrin and
transferrin are used as PrpL substrates. The conserved catalytic triad
of the amino acids serine (nucleophile), aspartate (electrophile), and
histidine (base) suggests that PrpL is a serine protease. Typically,
serine proteases are active at neutral and alkaline pHs, with an
optimum between 7 and 11. PrpL degraded lactoferrin when assays were
done at pHs of 7.5 to 9.0, with a pH of 7.5 being optimal (data not
shown). Lactoferrin that was digested with precipitated extracellular
proteins from P. aeruginosa
prpL::Gm resulted in little to no
detectable cleavage products (Fig. 4A).
The effect of temperature on PrpL activity was also investigated.
Cleavage of lactoferrin was detected at temperatures ranging from 23 to
42°C (Fig. 4B). Using rabbit anti-human lactoferrin, analysis of the
cleavage products confirmed that the cleavage products generated when
lactoferrin was incubated with extracellular proteins from P. aeruginosa PAO1 are by-products of lactoferrin and not of
contaminants from the commercially available lactoferrin used in the
assay (Fig. 4C). No such cleavage products were detected when
lactoferrin was incubated with extracellular proteins from P. aeruginosa
prpL::Gm (Fig. 4C).
When supernatants were incubated with transferrin, only very faint
degradation products were detected, indicating that PrpL degrades
transferrin, but not to the extent that it degrades lactoferrin (Fig.
4D). In addition to degrading lactoferrin, PrpL degrades elastin. In
the colorimetric elastin-Congo red assay, elastin degradation is
measured as the Congo red is released and becomes soluble in aqueous
buffer. Our results indicate that elastase activity was approximately
100 times greater in PAO1 than in supernatants from
prpL::Gm (data not shown). Finally,
decorin, a dermatan sulfate-containing proteoglycan, is also a
substrate for PrpL (Fig. 4E).
|
Incidence of prpL in Pseudomonas spp An assortment of P. aeruginosa strains, including clinical and environmental isolates, and one strain of P. putida were analyzed by Southern blot hybridization using probes containing sequences internal to prpL. Data from these experiments indicate that 40 of the 41 P. aeruginosa strains examined carry sequences homologous to prpL (data not shown). Sequences homologous to prpL were not detected in the one strain of P. putida examined (data not shown).
Analysis of PrpL expression levels and activity in various
P. aeruginosa strains.
Although sequences internal
to prpL were detected in all of the P. aeruginosa strains examined, it cannot be assumed that all of the
strains produce PrpL. As shown in Fig. 5,
there is variation in the PrpL levels, and in the overall amount of
secreted proteins, in the P. aeruginosa strains examined. In
addition, protease activity from these strains was analyzed by
comparing the zones of hydrolysis on BHI skim milk plates from culture
supernatants (Fig. 5). Together, these results indicate that the level
of PrpL produced correlates with the protease activity of the strains.
|
Competition studies in a chronic pulmonary infection model.
The ability of a P. aeruginosa PAO1 strain that is deficient
in the production of PrpL (
prpL::Gm)
to compete with parental wild-type strain PAO1 in a model infection was
examined. The rat lung agarose bead model was chosen for these studies
(8). Rats were simultaneously challenged by intratracheal
instillation of 107 to 108
P. aeruginosa PAO1 and
prpL::Gm organisms encased in
agarose beads. The lungs were harvested at 7 days postinfection, and
the numbers of PAO1 and
prpL::Gm
bacteria were evaluated by plate counts on media with and without
gentamicin. In this study, the total infectious dose of PAO1 and
prpL::Gm cells was 1.6 × 108 CFU and the ratio of PAO1 to
prpL::Gm was 1.5. In the rats
harvested at 7 days, the ratio of PAO1 to
prpL::Gm mutant cells recovered from
the rats varied from 14:1 to >100,000:1, with an average of 23,416:1
(Table 3). These data suggest that the
prpL::Gm mutant has a reduced
capacity to persist in this model after 1 week in competition with the
PAO1 parental strain.
|
Iron and PvdS regulation of prpL.
A
diagrammatic representation of the prpL locus is shown in
Fig. 6A. To confirm that prpL
is iron and PvdS regulated, expression of prpL was analyzed
at the transcriptional level by an RNase protection assay using a
riboprobe spanning the prpL promoter. Although numerous
transcripts were detected, a major protected mRNA fragment of 155 ± 5 nucleotides was detected, which corresponds to a transcriptional
start site at
65 nucleotides upstream of the prpL start
codon (Fig. 6A and B). Transcripts were detected from RNA isolated from
cultures grown for 6 and 10 h under low-iron conditions, with the
message level increasing with time. Although a very faint band was
detected in the
pvdS::Gm mutant,
levels are dramatically decreased in the
pvdS::Gm mutant compared to those in
PAO1 (Fig. 6B). Levels of transcription were also examined under
microaerobic conditions. Again, a major transcript was detected at
10 h when the cultures were grown under low-iron conditions; however, this level was significantly lower than that detected under
aerobic conditions (Fig. 6B). Transcription of the constitutively expressed omlA gene was also analyzed from the same RNA
samples and was constant at all time points (data not shown),
indicating that equivalent amounts of RNA were used in the reactions.
Together, these data indicate that PvdS regulates prpL.
|
Role of PtxR in regulation of prpL.
In an
iron-limiting environment, Fur positively regulates pvdS and
PvdS, in turn, can regulate other genes directly or through other
proteins, such as the LysR regulator PtxR. To determine if PvdS
directly regulates expression of prpL or if it acts through PtxR, levels of prpL expression were examined in P. aeruginosa PAO1,
pvdS::Gm, and
ptxR::Gm. A 727-bp riboprobe
generated from a sequence internal to the prpL coding
sequence was used in RNase protection assays (Fig. 6A). As shown in
Fig. 6C, prpL mRNA levels from either PAO1 or
ptxR::Gm were decreased when
cultures were grown in a low-iron medium rather than a high-iron
medium. In contrast, no significant difference in expression levels was
detected in
pvdS::Gm, supporting the
conclusion that prpL is regulated by PvdS. These data
indicate that while prpL is regulated by PvdS, it is not
regulated by PtxR.
| |
DISCUSSION |
|---|
|
|
|---|
Understanding the environmental cues responsible for the expression of virulence factors continues to be a focus of research in microbial pathogenesis. In P. aeruginosa, two major players involved in iron regulation are Fur and PvdS, which directly or indirectly regulate other genes, such as regulatory genes (e.g., ptxR and regA), genes required for iron acquisition (e.g., siderophores), and genes contributing to virulence (e.g., toxA). Here, we present evidence that PvdS also regulates prpL, a gene encoding an extracellular endoprotease.
Proteases are responsible for a variety of complex physiological and pathogenic functions in bacteria. They are intimately involved in protein turnover, enzyme modification and processing, gene regulation, and acquisition of nutrients. Moreover, microbial proteases can be involved in activating eukaryotic proteases that, in turn, can have potent pathogenic consequences. Because iron is an essential microelement required for most living organisms, the ability of P. aeruginosa to scavenge iron from its environment, whether that be the soil or a mammalian host, is essential. P. aeruginosa carries a redundant armamentarium of genes responsible for iron acquisition that may ultimately induce tissue injury. For example, elastase is able to degrade both lactoferrin and transferrin, thereby increasing the availability of iron for P. aeruginosa (11). Elastase can also degrade immunoglobulin (10, 20), collagen (21), and elastin (31, 60). Finally, elastase can act synergistically with alkaline protease to inactivate the human cytokines gamma interferon and tumor necrosis factor alpha (37).
Protease activity in P. aeruginosa has been correlated with
the site of isolation (24) and has been used as a
predictor of potential invasiveness (25). For example,
elastase and increased protease activities were associated
preferentially with clinical isolates of systemic origin, suggesting
that they may play a role in dissemination from local or superficial
sites (25). In the past, it has been recognized that some
of the protease production in P. aeruginosa is regulated by
iron. However, to our knowledge, no specific genes encoding specific
proteases have been identified that are also known to be regulated by
proteins such as PvdS and Fur. Elastase production is regulated by
quorum sensing (39) and by zinc at the translational level
(7). In this study, comparison of pyoverdine production
and proteolytic and elastolytic activities in P. aeruginosa
PAO1 and a
pvdS::Gm mutant indicated that PvdS is either directly or indirectly involved in the regulation of such activities. Analysis of extracellular proteins from P. aeruginosa PAO1 and the
pvdS::Gm mutant led to the
identification of several proteins present in P. aeruginosa
PAO1 but not detected in
pvdS::Gm
(Fig. 1). The N terminus of the 27-kDa protease described here is
identical to that of protease IV described by Engel et al.
(12) in P. aeruginosa strain PA103-29. Although
the gene encoding protease IV has not been identified, Engel et al.
demonstrated that a protease IV-deficient strain had reduced corneal
virulence compared to that of PA103-29 in both a rabbit intrastromal
model and a mouse topical model of infection (13, 14). In
addition, amino acid analysis revealed that the N terminus of this
27-kDa protein is homologous to the N terminus of an ArgC endoprotease from L. enzymogenes. A genome search for this N terminus led
to the nucleotide sequence of this endoprotease and subsequent cloning of the gene from P. aeruginosa PAO1 encoding a protein that
is 44% identical to the L. enzymogenes endoprotease (Fig.
2). Analysis of the predicted amino acid sequence of PrpL revealed that
the active site containing the Ser-His-Asp triad in the endoprotease of
L. enzymogenes is conserved in the P. aeruginosa
endoprotease. Also of interest is the Arg-Gly-Asp (RGD) motif present
in the endoprotease from P. aeruginosa (Fig. 2). The RGD
motif is critical for ligand recognition by many integrins
(57). Streptococcus pyogenes produces a
cysteine protease (SpeB), a major virulence factor (29),
containing an RGD motif that binds host cell integrin (51). The crystal structure of SpeB revealed that this
motif, indeed, has a surface location (26). Studies to
investigate the significance of this RGD motif are under way.
Lactoferrin and transferrin are normal components of airway secretions
(52) and contribute to host defense in two major ways.
First, they limit the availability of iron for use by microbial pathogens. Second, when iron is bound to these proteins, it is unable
to catalyze hydroxyl radical formation from neutrophil-derived superoxide and hydrogen peroxide in the Haber-Weiss reaction
(2). If the formation of these superoxides and hydrogen
peroxides occurs, they can contribute to lung injury. P. aeruginosa counteracts these iron-binding proteins with its
siderophores pyoverdine and pyochelin. Ankenbauer et al.
(1) have shown that pyoverdine and pyochelin promote the
growth of P. aeruginosa when they are added to medium with
iron-transferrin or human serum as the iron source. Döring et al.
(11) have shown that cleavage of diferric transferrin by
elastase enhances the ability of the P. aeruginosa pyoverdine to obtain iron. In addition, cleavage of ferritransferrin by
elastase generates an iron chelate(s) which may be a highly effective
catalyst for the Haber-Weiss reaction (5). Therefore, proteases may act cooperatively to increase the availability of free
iron and cause tissue damage. Our data demonstrate that extracellular proteins from P. aeruginosa PAO1 can degrade lactoferrin
and, to a lesser extent, transferrin (Fig. 4A and D). In addition to degrading iron-binding proteins, PrpL has elastase activity (data not
shown) which may be advantageous in an in vivo environment by causing
cell damage. Finally, the ability of PrpL to degrade decorin may have
some significant consequences during infection. Decorin is a
proteoglycan ubiquitously distributed in the extracellular matrix of
mammals. Upon degradation, decorin can release dermatan sulfate, which
can bind to neutrophil-derived
-defensin, neutralizing its
bactericidal activity (45).
Variation among strains in protease production has been documented
(24, 25, 31). In this study, all but one of the P. aeruginosa strains examined carry sequences homologous to
prpL (data not shown); however, expression of PrpL is
variable (Fig. 5). In addition, the protease activity of extracellular
proteins from the various strains correlates with PrpL production. Lack of expression in some of the strains could be due to a mutation in the
promoter region or perhaps a missense or nonsense mutation in the
coding region; however, this has not yet been investigated. In
addition, we have not ruled out the possibility that variation is
prpL expression is due to differences or mutations in
regulators of prpL. Strains that produce PrpL may have a
selective advantage in the lung due to their ability to scavenge iron
from lactoferrin and cause tissue damage. However, these experiments
did not exclude the possibility of the ability of the
prpL::Gm mutant strain to scavenge
the degradation products produced by the PrpL secreted by strain PAO1.
In this regard, we found that a P. aeruginosa
prpL::Gm mutant strain competes less
well with the parental PAO1 strain in competitive index studies in the
agarose bead rat lung model (Table 3).
Analysis of RNase protection assays indicated that prpL is indeed regulated by PvdS. As shown in Fig. 6B, we demonstrated that expression is increased under low-iron conditions, in comparison with high-iron conditions, during log growth under aerobic conditions. In contrast, transcription decreases in response to low oxygen tension. This pattern of transcriptional regulation is similar to that seen for the iron- and oxygen-regulated toxA gene, which encodes exotoxin A (33). In addition to PvdS, optimal expression of toxA requires PtxR (54), which belongs to the LysR family of regulators. Consequently, it seemed reasonable that PtxR may be required for prpL expression. However, as shown in Fig. 6C, PtxR does not affect transcription levels of prpL. These data and those of others (33) indicate that although PvdS regulates both toxA and prpL, there are important differences in the regulation of these iron-responsive genes. A DNA sequence motif was identified by Rombel et al. (41) that is required for promoter activity in several PvdS-dependent pyoverdine promoters. This iron starvation box has the consensus sequence for the pyoverdine genes of TAAAT-16 nucleotides (nt)-CGT and is located 10 nt before the +1 site (59). This sequence was also found in the exotoxin A promoters, in a P. putida siderophore promoter, and in a Pseudomonas sp. strain M114 iron-regulated promoter (41). Wilson and Lamont (58) proposed that the helix-turn-helix of PvdS recognizes this motif. Analysis of the sequence 5' to the transcription start site of prpL revealed a sequence that differs by only 1 nt from this consensus, suggesting that PvdS directly regulates prpL.
In summary, data presented here show that prpL encodes a PvdS-regulated endoprotease that degrades casein, lactoferrin, transferrin, elastase, and decorin. In the future, additional substrates for PrpL may be identified, as well as the steps involved in the processing of PrpL. In addition, it will be interesting to determine if PrpL levels correlate with invasiveness. Thus far, regulation of prpL has only been investigated with respect to iron and oxygen levels. Although we have shown that PtxR is not involved in the regulation of prpL, other regulatory factors may contribute to its regulation. The study presented here, identifying and characterizing a PvdS-regulated endoprotease, provides more evidence for the redundancy in the P. aeruginosa genome which contributes to its success as an opportunistic pathogen.
| |
ACKNOWLEDGMENTS |
|---|
We thank Urs Ochsner for technical assistance and valuable discussions. We thank Frank Accurso, Yoichi Hirakata, Joan Olson, and David Speert for providing strains used in this study.
This work was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI-15940) to M.L.V. and a fellowship from the CF Foundation (WILDER00F0) to P.J.W.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Campus Box B175, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Denver, CO 80262. Phone: (303) 315-8627. Fax: (303) 315-6785. E-mail: Mike.Vasil{at}UCHSC.edu.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ankenbauer, R.,
S. Sriyosachati, and C. D. Cox.
1985.
Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin.
Infect. Immun.
49:132-140 |
| 2. |
Baldwin, D. A.,
E. R. Jenny, and P. Aisen.
1984.
The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide.
J. Biol. Chem.
259:13391-13394 |
| 3. | Barton, H. A., Z. Johnson, C. D. Cox, A. I. Vasil, and M. L. Vasil. 1996. Ferric uptake regulator mutants of Pseudomonas aeruginosa with distinct alterations in the iron-dependent repression of exotoxin A and siderophores in aerobic and microaerobic environments. Mol. Microbiol. 21:10001-10017. |
| 4. | Boyer, H. W., and D. Rolland-Dussoix. 1969. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41:459-472[CrossRef][Medline]. |
| 5. | Britigan, B. E., and B. L. Edeker. 1991. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J. Clin. Investig. 88:1092-1102. |
| 6. |
Britigan, B. E.,
M. B. Hayek,
B. N. Doebbeling, and R. B. Fick, Jr.
1993.
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.
Infect. Immun.
61:5049-5055 |
| 7. | Brumlik, M. J., and D. G. Storey. 1992. Zinc and iron regulate translation of the gene encoding Pseudomonas aeruginosa elastase. Mol. Microbiol. 6:337-344[CrossRef][Medline]. |
| 8. | Cash, H. A., D. E. Woods, B. McCullough, W. G. Johanson, Jr., and J. A. Bass. 1979. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 119:453-459[Medline]. |
| 9. | de Lorenzo, V., L. Eltis, B. Kessler, and K. N. Timmis. 1993. Analysis of Pseudomonas gene products using lacIq/Ptrp-lac plasmids and transposons that confer conditional phenotypes. Gene 123:17-24[CrossRef][Medline]. |
| 10. | Döring, G., H. J. Obernesser, and K. Botzenhart. 1981. Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA. Zentralbl. Bakteriol. 249:89-98. |
| 11. |
Döring, G.,
M. Pfestorf,
K. Botzenhart, and M. A. Abdallah.
1988.
Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin.
Infect. Immun.
56:291-293 |
| 12. |
Engel, L. S.,
J. M. Hill,
A. R. Caballero,
L. C. Green, and R. J. O'Callaghan.
1998.
Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa.
J. Biol. Chem.
273:16792-16797 |
| 13. |
Engel, L. S.,
J. M. Hill,
J. M. Moreau,
L. C. Green,
J. A. Hobden, and R. J. O'Callaghan.
1998.
Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Investig. Ophthalmol. Vis. Sci.
39:662-665 |
| 14. |
Engel, L. S.,
J. A. Hobden,
J. M. Moreau,
M. C. Callegan,
J. M. Hill, and R. J. O'Callaghan.
1997.
Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
Investig. Ophthalmol. Vis. Sci.
38:1535-1542 |
| 15. | Farley, P. 1985. Ph.D. thesis. University of Otago, Dunedin, New Zealand. |
| 16. |
Ferguson, M. W.,
J. A. Maxwell,
T. S. Vincent,
J. da Silva, and J. C. Olson.
2001.
Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa.
Infect. Immun.
69:2198-2210 |
| 17. |
Figurski, D., and D. R. Helinski.
1979.
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.
Proc. Natl. Acad. Sci. USA
76:1648-1652 |
| 18. | Finkelstein, R. A., C. V. Sciortino, and M. A. McIntosh. 1983. Role of iron in microbe-host interactions. Rev. Infect. Dis. 5(Suppl. 4):S759-S777. |
| 19. |
Gambello, M. J., and B. H. Iglewski.
1991.
Cloning and characterization of the Pseudomonas aeruginosa lasR gene: a transcriptional activator of elastase expression.
J. Bacteriol.
173:3000-3009 |
| 20. | Heck, L. W., P. G. Alarcon, R. M. Kulhavy, K. Morihara, M. W. Russell, and J. F. Mestecky. 1990. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J. Immunol. 144:2253-2257[Abstract]. |
| 21. |
Heck, L. W.,
K. Morihara,
W. B. McRae, and E. J. Miller.
1986.
Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.
Infect. Immun.
51:115-118 |
| 22. | Hirakata, Y., B. B. Finlay, D. A. Simpson, S. Kohno, S. Kamihira, and D. P. Speert. 2000. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J. Infect. Dis. 181:765-769[CrossRef][Medline]. |
| 23. |
Holloway, B. W.,
V. Krishnapillai, and A. F. Morgan.
1979.
Chromosomal genetics of Pseudomonas.
Microbiol. Rev.
43:73-102 |
| 24. |
Janda, J. M.,
S. Atang-Nomo,
E. J. Bottone, and E. P. Desmond.
1980.
Correlation of proteolytic activity of Pseudomonas aeruginosa with site of isolation.
J. Clin. Microbiol.
12:626-628 |
| 25. |
Janda, J. M., and E. J. Bottone.
1981.
Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool.
J. Clin. Microbiol.
14:55-60 |
| 26. |
Kagawa, T. F.,
J. C. Cooney,
H. M. Baker,
S. McSweeney,
M. Liu,
S. Gubba,
J. M. Musser, and E. N. Baker.
2000.
Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease.
Proc. Natl. Acad. Sci. USA
97:2235-2240 |
| 27. | King, E. O., M. K. Ward, and D. E. Raney. 1954. Two simple media for the demonstration of pyocyanin and fluorescin. J. Lab. Clin. Med. 44:301-307[Medline]. |
| 28. | Lui, P. 1966. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease. J. Infect. Dis. 16:112-116. |
| 29. | Lukomski, S., S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J. M. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Investig. 99:2574-2580[Medline]. |
| 30. | Meyer, J. M., and M. A. Abdallah. 1978. The fluorescent pigment of Pseudomonas fluorescens: biosynthesis, purification and physicochemical properties. J. Microbiol. 107:319-328. |
| 31. |
Morihara, K.
1964.
Production of elastase and proteinase by Pseudomonas aeruginosa.
J. Bacteriol.
88:745-757 |
| 32. |
Nunn, D.,
S. Bergman, and S. Lory.
1990.
Products of three accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudomonas aeruginosa pili.
J. Bacteriol.
172:2911-2919 |
| 33. | Ochsner, U. A., Z. Johnson, I. L. Lamont, H. E. Cunliffe, and M. L. Vasil. 1996. Exotoxin A production in Pseudomonas aeruginosa requires the iron-regulated pvdS gene encoding an alternative sigma factor. Mol. Microbiol. 21:1019-1028[CrossRef][Medline]. |
| 34. |
Ochsner, U. A., and M. L. Vasil.
1996.
Gene repression by the ferric uptake regulator in Pseudomonas aeruginosa: cycle selection of iron-regulated genes.
Proc. Natl. Acad. Sci. USA
93:4409-4414 |
| 35. |
Ohman, D. E.,
S. J. Cryz, and B. H. Iglewski.
1980.
Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.
J. Bacteriol.
142:836-842 |
| 36. |
Olson, J. C., and D. E. Ohman.
1992.
Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.
J. Bacteriol.
174:4140-4147 |
| 37. |
Parmely, M.,
A. Gale,
M. Clabaugh,
R. Horvat, and W. W. Zhou.
1990.
Proteolytic inactivation of cytokines by Pseudomonas aeruginosa.
Infect. Immun.
58:3009-3014 |
| 38. |
Passador, L.,
J. M. Cook,
M. J. Gambello,
L. Rust, and B. H. Iglewski.
1993.
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication.
Science
260:1127-1130 |
| 39. |
Pearson, J. P.,
E. C. Pesci, and B. H. Iglewski.
1997.
Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes.
J. Bacteriol.
179:5756-5767 |
| 40. |
Rahme, L. G.,
E. J. Stevens,
S. F. Wolfort,
J. Shao,
R. G. Tompkins, and F. M. Ausubel.
1995.
Common virulence factors for bacterial pathogenicity in plants and animals.
Science
268:1899-1902 |
| 41. | Rombel, I. T., B. J. McMorran, and I. L. Lamont. 1995. Identification of a DNA sequence motif required for expression of iron-regulated genes in pseudomonads. Mol. Gen. Genet. 246:519-528[CrossRef][Medline]. |
| 42. | Rust, L., C. R. Messing, and B. H. Iglewski. 1994. Elastase assays. Methods Enzymol. 235:554-562[Medline]. |
| 43. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 44. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 45. |
Schmidtchen, A.,
I.-M. Frick, and L. Bjorck.
2001.
Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial -defensin.
Mol. Microbiol.
39:708-713[CrossRef][Medline].
|
| 46. | Schweizer, H. P., and T. T. Hoang. 1995. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158:15-22[CrossRef][Medline]. |
| 47. | Simon, R., U. Priefer, and A. Puehler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Bio/Technology 1:784-791[CrossRef]. |
| 48. |
Sokol, P. A.,
D. E. Ohman, and B. H. Iglewski.
1979.
A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa.
J. Clin. Microbiol.
9:538-540 |
| 49. | Stanislavsky, E. S., T. A. Makarenko, and T. E. Kozhenova. 1992. Specific and nonspecific mouse protection induced by different chemotypes of the Pseudomonas aeruginosa lipopolysaccharide. FEMS Microbiol. Immun. 105:181-190[CrossRef]. |
| 50. |
Stintzi, A.,
Z. Johnson,
M. Stonehouse,
U. Ochsner,
J. M. Meyer,
M. L. Vasil, and K. Poole.
1999.
The pvc gene cluster of Pseudomonas aeruginosa: role in synthesis of the pyoverdine chromophore and regulation by PtxR and PvdS.
J. Bacteriol.
181:4118-4124 |
| 51. |
Stockbauer, K. E.,
L. Magoun,
M. Liu,
E. H. Burns,
S. Gubba,
S. Renish,
X. Pan,
S. C. Bodary,
E. Baker,
J. Coburn,
J. M. Leong, and J. M. Musser.
1999.
A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3.
Proc. Natl. Acad. Sci. USA
96:242-247 |
| 52. | Thompson, A. B., T. Bohling, F. Payvandi, and S. I. Rennard. 1990. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J. Lab. Clin. Med. 115:148-158[Medline]. |
| 53. |
Vasil, M. L.,
C. Chamberlain, and C. C. Grant.
1986.
Molecular studies of Pseudomonas exotoxin A gene.
Infect. Immun.
52:538-548 |
| 54. |
Vasil, M. L.,
U. A. Ochsner,
Z. Johnson,
J. A. Colmer, and A. N. Hamood.
1998.
The Fur-regulated gene encoding the alternative sigma factor PvdS is required for iron-dependent expression of the LysR-type regulator PtxR in Pseudomonas aeruginosa.
J. Bacteriol.
180:6784-6788 |
| 55. | Venturi, V., C. Ottevanger, M. Bracke, and P. Weisbeek. 1995. Iron regulation of siderophore biosynthesis and transport in Pseudomonas putida WCS358: involvement of a transcriptional activator and of the Fur protein. Mol. Microbiol. 18:1081-1093. |
| 56. |
West, S. E., and B. H. Iglewski.
1988.
Codon usage in Pseudomonas aeruginosa.
Nucleic Acids Res.
16:9323-9335 |
| 57. | Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319[CrossRef][Medline]. |
| 58. | Wilson, M. J., and I. L. Lamont. 2000. Characterization of an ECF sigma factor protein from Pseudomonas aeruginosa. Biochem Biophys Res. Commun. 273:578-583[CrossRef][Medline]. |
| 59. |
Wilson, M. J.,
B. J. McMorran, and I. L. Lamont.
2001.
Analysis of promoters recognized by PvdS, an extracytoplasmic-function sigma factor protein from Pseudomonas aeruginosa.
J. Bacteriol.
183:2151-2155 |
| 60. |
Wretlind, B., and T. Wadstrom.
1977.
Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa.
J. Gen. Microbiol.
103:319-327 |
| 61. | Wright, D. S., L. D. Graham, and P. A. Jennings. 1998. Cloning a Lysobacter enzymogenes gene that encodes an arginyl endopeptidase (endoproteinase Arg-C). Biochim. Biophys. Acta 143:369-374. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»